MonaLisa Touch®: The latest Frontier in the treatment of Vaginal Atrophy
Vaginal atrophy is a widespread condition in females, especially in menopause. The genital tract is indeed particularly sensitive to the decrease in oestrogen levels and approximately half of all post-menopausal women experience symptoms that are typical of genital atrophy and deeply affect sexual function as well as quality of life. While hot flushes and night sweats naturally disappear overtime, the symptoms associated with vaginal and urethral atrophy often get worse and, in most cases, require targeted treatment.
MonaLisa Touch® allows for natural rejuvenation of the vaginal mucosa. By restoring the pre-menopausal structure of tissues, it is also possible to recover the functionality that the vaginal mucosa has lost due to the ageing process. MonaLisa Touch® was first available outside the US where more than 15,000 patients have been treated worldwide
MonaLisa Touch® using DEKA’s SmartXide2 CO2 Laser + V2LR Vaginal Scanner + Handpieces is a FDA- approved procedure.